Based on recent data, ArriVent BioPharma, Inc. Common Stock (AVBP) shows an Average True Range (ATR) of 1.38 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 480.92K, indicating liquidity. These fundamental metrics provide insight into AVBP's underlying financial health and market activity.
| ATR | 1.38 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 480.92K |
| Avg Vol (10 Days) | 366.52K |
ArriVent BioPharma, Inc. Common Stock (AVBP) technical indicators as of March 18, 2026: the SMA 20 is 3.26%, SMA 50 at 5.34%, and SMA 200 at 11.15%. The RSI 14 value is 56.48, suggesting its current momentum. These technical analysis signals help assess AVBP's price trends and potential future movements.
| SMA 20 | 3.26% |
| SMA 50 | 5.34% |
| SMA 200 | 11.15% |
| RSI 14 | 56.48 |
ArriVent BioPharma, Inc. Common Stock (AVBP) stock performance overview as of March 18, 2026: The 52-week high is $26.86 (currently -11.76% below), and the 52-week low is $15.47 (currently 50.16% above). Over the past year, AVBP's performance is -9.07%, compared to the S&P 500's 17.63% change.
| 52-Week High | 26.86 |
| 52-Week High Chg | -11.76% |
| 52-Week Low | 15.47 |
| 52-Week Low Chg | +50.16% |
| S&P 500 52-Week Chg | 17.63% |
According to market data, ArriVent BioPharma, Inc. Common Stock (AVBP) stock's recent performance metrics show that over the last month, AVBP is 0.09%, with a Year-to-Date (YTD) performance of 10.64%. Over the past year, the stock has seen a -9.07% change. These figures summarize AVBP's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 25 | 26.86 | 26.86 | 26.86 | 26.86 | 26.86 |
| Low | 22.63 | 21.9 | 18.2 | 17 | 15.47 | 18.2 |
| Performance | +8.90% | +0.09% | +14.10% | +3.29% | -9.07% | +10.64% |
According to current financial data, AVBP stock's P/E (TTM) ratio is -5.28, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for AVBP, including P/S (N/A), P/B (2.86), and P/FCF (-6.29), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AVBP | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -5.28 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 2.86 | 58.95 | 5.21 | 4.58 |
| P/FCF (TTM) | -6.29 | 61.81 | -197.65 | 31.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep